UPNEX HEALTH

Health is changing fast. We make it make sense.

Exploring the Future of Male Contraceptives: What You Need to Know About the ADAM Implant

Recent advancements in male contraception have led to the development of the ADAM implant by Contraline, a non-hormonal and reversible method that physically blocks sperm ducts. Clinical trials show it effectively prevents sperm production for up to two years, offering a flexible and low-maintenance alternative to traditional methods like condoms and vasectomies.

•

1–2 minutes

Sources and References

Anderson, Paul, Damien Bolton, and Nathan Lawrentschuk. “Preliminary Results of a First in Human Dose-Ranging Clinical Trial of ADAM®, a Nonhormonal Hydrogel-Based Male Contraceptive.” The Journal of Urology, vol. 209, no. Supplement 4, Apr. 2023, e1114. https://doi.org/10.1097/JU.0000000000003352.08.

Contraline. “Non-Hormonal Male Contraceptive Implant: ADAM.” 2025, https://www.contraline.com/.

Davis, Nicola. “Non-Hormonal Male Contraceptive Implant Lasts at Least Two Years in Trials.” The Guardian, 24 Apr. 2025, https://www.theguardian.com/science/2025/apr/24/non-hormonal-male-contraceptive-implant-lasts-two-years-trials.

Gooch, Bryony. “Male Non-Hormonal Contraceptive Implant Shown to Work for 24 Months in Trials.” The Independent, 24 Apr. 2025, https://www.independent.co.uk/science/male-non-hormonal-contraceptive-implant-adam-b2343456.

UpNEX Health's avatar

UpNEX Health

Leave a comment

Pages: 1 2

Get the UpNEX Health Brief.

A concise, evidence-based briefing on the health stories worth knowing, sent once a month.

Subscribe →

You might also like…